We observed the dosage-dependent deregulation of numerous cancer driver genes, as well as of expression programs involving the gradual downregulation of proliferation and upregulation of apoptosis and cellular senescence, as an immediate- or intermediate–early response to Smarca5 knockout induction in the primary MEFs. This evidence concerns the gene SMARCA5 and cancer.